[Form 4] VolitionRX Limited Insider Trading Activity
Rhea-AI Filing Summary
On 08/05/2025, VolitionRx Ltd. (VNRX) director Guy Archibald Innes filed Form 4 reporting the purchase of 78,125 common shares at $0.64 per share, executed through the company’s registered direct offering. The transaction lifts his direct holding to 966,814 shares.
The filing also lists significant indirect ownership: 1,400,000 shares held by The Innes Family Bare Trust 2023 (where Innes is trustee), 356,000 shares held by The Dill Faulkes Educational Trust Ltd., and a combined 618,014 shares registered in the names of his son (309,006) and daughter (309,008). Innes shares voting/dispositive control over these blocks and disclaims beneficial ownership of the DFET position beyond any pecuniary interest.
No derivative securities were reported, and the form was signed on 08/06/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR — Director bought 78k shares, raising direct stake to ~0.97 M; insider alignment strengthened.
Innes’ $0.64 purchase adds roughly $50k of fresh capital and brings his direct ownership to nearly one million shares. Including trusts and family accounts, disclosed beneficial ownership surpasses 2.9 M shares, or a meaningful portion of VolitionRx’s public float. No sales or derivative activity were reported, indicating net accumulation. Insider buying—especially in a financing context—can be interpreted as confidence in forthcoming milestones, though the purchase size is modest relative to total indirect holdings. Overall impact leans positive, signalling alignment with minority shareholders and removing the overhang of insider selling concerns.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 78,125 | $0.64 | $50K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Acquired at the offering price in the registered direct offering of Common Stock by VolitionRx. These shares of Common Stock are beneficially owned by The Innes Family Bare Trust 2023, which is a separate legal entity, of which the reporting person is the Trustee, for the benefit of his children. These shares of Common Stock are beneficially owned by The Dill Faulkes Educational Trust Limited ("DFET"), a UK registered charity. The reporting person serves as a director and trustee of DFET and shares voting and dispositive control over these shares but disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
